Overview

Indirect Comparison Between Eltrombopag & Romiplostim

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
An indirect comparison to compare the efficacy of eltrombopag versus romiplostim
Details
Lead Sponsor:
GlaxoSmithKline